A verification study of the reduction effect of the test food consumption on blood pressure
- Conditions
- Healthy Japanese subjects
- Registration Number
- JPRN-UMIN000051047
- Lead Sponsor
- ORTHOMEDICO Inc.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 68
Not provided
1. Subjects who are undergoing medical treatment or have a medical history of malignant tumor, heart failure, and myocardial infarction 2. Subjects who have a pacemaker or an implantable cardioverter defibrillator (ICD) 3. Subjects currently undergoing treatment for any of the following chronic diseases: cardiac arrhythmia, liver disorder, kidney disorder, cerebrovascular disorder, rheumatism, diabetes mellitus, dyslipidemia, hypertension, or any other chronic diseases 4. Subjects who use or take "Foods for Specified Health Uses," or "Foods with Functional Claims" in daily 5. Subjects who are currently taking medications (including herbal medicines) and supplements 6. Subjects who are allergic to medicines and/or the test food related products 7. Subjects who are a smoker 8. Subjects who are pregnant, lactating, or planning to become pregnant during this trial 9. Subjects who have been enrolled in other clinical trials within the last 28 days before the agreement to participate in this trial or plan to participate another trial during this trial 10. Subjects who are judged as ineligible to participate in this study by the physician
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. The measured value of systolic blood pressure at 12 weeks after consumption (12w)
- Secondary Outcome Measures
Name Time Method 1. The amount of changes from screening (before test-food consumption; Scr) in systolic blood pressure at 12w 2. The measured value of systolic blood pressure at four and eight weeks after consumption (4w and 8w), and the amount of changes from Scr 3. The measured values of diastolic blood pressure at 4w, 8w, and 12w, and the amount of changes from Scr 4. The subjects who have 129 mmHg or less of systolic blood pressure and 89 mmHg or less of diastolic blood pressure at 12w